Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice.

Goya RG, Reggiani PC, Vesenbeckh SM, Pléau JM, Sosa YE, Cónsole GM, Schade R, Henklein P, Dardenne M.

Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E182-7. Epub 2007 Mar 27.

2.

Neonatal thymulin gene therapy prevents ovarian dysgenesis and attenuates reproductive derangements in nude female mice.

Reggiani PC, Barbeito CG, Zuccolilli GO, Cónsole GM, Flamini AM, Dardenne M, Goya RG.

Endocrinology. 2012 Aug;153(8):3922-8. doi: 10.1210/en.2012-1183. Epub 2012 Jun 14.

3.

Morphological restoration of gonadotrope population by thymulin gene therapy in nude mice.

Reggiani P, Martines E, Ferese C, Goya R, Cónsole G.

Histol Histopathol. 2009 Jun;24(6):729-35. doi: 10.14670/HH-24.729.

4.

Neonatal thymulin gene therapy in nude mice: Effects on the morphology of the pituitary corticotrope population.

Martines E, Reggiani PC, Schwerdt JI, Goya RG, Cónsole G.

Histol Histopathol. 2011 Apr;26(4):471-9. doi: 10.14670/HH-26.471.

PMID:
21360440
5.

The thymulin-lactotropic axis in rodents: thymectomy, immunoneutralization and gene transfer studies.

Martines EV, Reggiani PC, Camihort G, Luna G, Zappa MF, Brown OA, Goya RG, Cónsole GM.

Neuroimmunomodulation. 2013;20(5):256-63. doi: 10.1159/000346477. Epub 2013 Jul 9.

PMID:
23941809
6.

Role of thymulin on the somatotropic axis in vivo.

Reggiani PC, Martines EV, Camihort GA, Poch B, Goya RG, Cónsole GM.

Life Sci. 2012 Sep 4;91(5-6):166-71. doi: 10.1016/j.lfs.2012.06.037. Epub 2012 Jul 8.

PMID:
22781709
7.

Thymulin gene therapy prevents the histomorphometric changes induced by thymulin deficiency in the thyrotrope population of mice.

Martines EV, Reggiani PC, Schwerdt JI, Goya RG, Cónsole GM.

Cells Tissues Organs. 2011;194(1):67-75. doi: 10.1159/000322583. Epub 2011 Jan 7.

PMID:
21212643
8.

Potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models.

Morel GR, Reggiani PC, Console GM, Rimoldi OJ, Vesenbeckh SM, Garcia-Bravo MM, Rodriguez SS, Brown OA, Goya RG.

Curr Gene Ther. 2008 Feb;8(1):49-53. Review.

PMID:
18336249
9.

Morphometric assessment of the impact of serum thymulin immunoneutralization on pituitary cell populations in peripubertal mice.

Camihort G, Luna G, Vesenbeckh S, Ferese C, Dardenne M, Goya R, Cónsole G.

Cells Tissues Organs. 2006;184(1):23-30.

PMID:
17190977
10.

Partial prevention of hepatic lipid alterations in nude mice by neonatal thymulin gene therapy.

García de Bravo MM, Polo MP, Reggiani PC, Rimoldi OJ, Dardenne M, Goya RG.

Lipids. 2006 Aug;41(8):753-7.

PMID:
17120928
11.

Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats.

Reggiani PC, Hereñú CB, Rimoldi OJ, Brown OA, Pléau JM, Dardenne M, Goya RG.

Gene Ther. 2006 Aug;13(16):1214-21. Epub 2006 Apr 13.

PMID:
16617301
12.

Thymulin-based gene therapy and pituitary function in animal models of aging.

Reggiani PC, Poch B, Cónsole GM, Rimoldi OJ, Schwerdt JI, Tüngler V, Garcia-Bravo MM, Dardenne M, Goya RG.

Neuroimmunomodulation. 2011;18(5):350-6. doi: 10.1159/000329495. Epub 2011 Sep 22.

13.

Thymus and aging: potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models.

Goya RG, Cónsole G, Hereñú C, Brown O, Rimoldi OJ.

Gerontology. 2002 Sep-Oct;48(5):325-8.

PMID:
12169800
14.

The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin.

Reggiani PC, Morel GR, Cónsole GM, Barbeito CG, Rodriguez SS, Brown OA, Bellini MJ, Pléau JM, Dardenne M, Goya RG.

Ann N Y Acad Sci. 2009 Feb;1153:98-106. doi: 10.1111/j.1749-6632.2008.03964.x. Review.

15.

Peripheral and mesencephalic transfer of a synthetic gene for the thymic peptide thymulin.

Morel GR, Brown OA, Reggiani PC, Hereñú CB, Portiansky EL, Zuccolilli GO, Pléau JM, Dardenne M, Goya RG.

Brain Res Bull. 2006 May 31;69(6):647-51. Epub 2006 Apr 18.

PMID:
16716832
16.

Effects of infantile thymectomy on ovarian functions and gonadotrophin-induced ovulation in prepubertal mice: role of thymulin.

García L, Hinojosa L, Domínguez R, Chavira R, Rosas P.

J Endocrinol. 2000 Aug;166(2):381-7.

17.

A new adenovector system for implementing thymulin gene therapy for inflammatory disorders.

Zappa-Villar MF, López-León M, Pardo J, Costa M, Crespo R, Dardenne M, Goya RG, Reggiani PC.

Mol Immunol. 2017 Jul;87:180-187. doi: 10.1016/j.molimm.2017.04.014. Epub 2017 May 11.

PMID:
28501652
18.

Physiology and therapeutic potential of the thymic peptide thymulin.

Reggiani PC, Schwerdt JI, Console GM, Roggero EA, Dardenne M, Goya RG.

Curr Pharm Des. 2014;20(29):4690-6. Review.

PMID:
24588820
19.

In vivo and in vitro studies of thymulin in marginally zinc-deficient mice.

Dardenne M, Savino W, Wade S, Kaiserlian D, Lemonnier D, Bach JF.

Eur J Immunol. 1984 May;14(5):454-8.

PMID:
6609827
20.

A new radioimmunoassay for the thymic peptide thymulin, and its application for measuring thymulin in blood samples.

Safieh B, Kendall MD, Norman JC, Metreau E, Dardenne M, Bach JF, Pleau JM.

J Immunol Methods. 1990 Mar 9;127(2):255-62.

PMID:
2313103

Supplemental Content

Support Center